← Eichor
Condition: Sglt2 Inhibitors Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Sglt2 Inhibitors

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Impact of SGLT2 Inhibitors on Chronic Peritoneal Dialysis Patients.
NA · 1 location(s) · Oman Ministry of Health · NCT07491042The Efficacy and Safety of Sodium-glucose Cotransporter 2 Inhibitors in Patients With Acute Kidney Disease
Phase 2 · 1 location(s) · National Taiwan University Hospital · NCT06528405SGLT2 Inhibitor TrEatment iN Patients Awaiting cOronary arTery bYpass Surgery to Reduce Post-opErative AF
Phase 3 · 8 location(s) · Region Örebro County · NCT05852704Study Targeting Myocardial Perfusion and Symptom Relief in Women With SGLT2 Inhibitors (STRONG)
Phase 1 · 1 location(s) · University of Virginia · NCT06600178Effects of Continued Administration of Empagliflozin in Patients With Heart Failure on Active SGLT2 Inhibitor Treatment
Phase 3 · 9 location(s) · Christian Schulze · NCT07038356Improving Coronary Vascular Health in Women
Phase 2 · 1 location(s) · Massachusetts General Hospital · NCT06843902Effect of Empagliflozin on Metabolic Outcomes in Adults Living With HIV Receiving Dolutegravir-Based Therapy
Phase 2 · 1 location(s) · Abdelrahman Mahmoud · NCT07336797Effect at 3 Months of Early Empagliflozin Initiation in Cardiogenic Shock Patients on Mortality, Rehospitalization, Left
Phase 3 · 8 location(s) · Central Hospital, Nancy, France · NCT05879276Transformative Research in Diabetic Nephropathy 2.0
Phase N/A · 1 location(s) · University of Pennsylvania · NCT07444203Targeting Pediatric Brain Tumors and Relapsed/Refractory Solid Tumors With Sodium Glucose Cotransporter 2 Inhibitors (SG
Phase 1 · 1 location(s) · Washington University School of Medicine · NCT05521984Efficacy and Safety Comparison of Cofrogliptin Add-on Versus Metformin Dose-escalation in Type 2 Diabetes Patients Inade
NA · 1 location(s) · Second Affiliated Hospital, School of Medicine, Zhejiang Uni · NCT06863532SGLTi, Hepatic Glucose Production and Ketogenesis
Phase 1 · 1 location(s) · The University of Texas Health Science Center at San Antonio · NCT05960656Acetazolamide Versus Dapagliflozin in Acute Decompensated Heart Failure Patients
Phase 3 · 1 location(s) · Helwan University · NCT06535529CAMEO-FONTAN -Dapagliflozin in the Failing Fontan Circulation
Phase 2 · 1 location(s) · Mayo Clinic · NCT06762964Clinical Investigation of the Cardioprotective Effect of Early Administration of SGLT2 in Patients Presented With AMI
NA · 1 location(s) · Mohammad Hussien Tantawy Soliman · NCT06009874SGLT2i Safety and Efficacy on Kidney Allograft Function in Non-diabetic Kidney Transplant Recipients
Phase 4 · 1 location(s) · Odense University Hospital · NCT07143773Dapagliflozin in Active Lupus Nephritis
Phase 4 · 2 location(s) · Brigham and Women's Hospital · NCT07323524Vascular Complications in Patients Undergoing Peripheral Revascularization and Taking SGLT-2 Inhibitors
Phase N/A · 1 location(s) · Wroclaw Medical University · NCT07157475Delayed Initiation of ARNI and SGLT2i in Heart Failure With Corrected Aetiology (DELAY-HF), Pilot Study
Phase 4 · 4 location(s) · Kyungsub Song · NCT07572032Dapagliflozin in Depression
Phase 1/Phase 2 · 1 location(s) · Tanta University · NCT07239011Dapagliflozin Plus Pioglitazone in T1DM
Phase 4 · 3 location(s) · The University of Texas Health Science Center at San Antonio · NCT03878459meChANisms and sAfety of SGLT2 Inhibition in peRitoneal dialYsis
Phase 3 · 1 location(s) · University Health Network, Toronto · NCT05715814SGLT2 Inhibitors on Coronary Atherosclerosis Progression Via Perivascular Adipose Tissue in Diabetes
Phase 4 · 2 location(s) · Junjie Yang · NCT07614230Strategic Lifestyle Intervention for Metabolic Syndrome (SLIM-MET)
NA · 1 location(s) · National Health Research Institutes, Taiwan · NCT06271200SGLT2 Inhibitor in Lupus Nephritis Patients With Chronic Kidney Disease
Phase 2 · 1 location(s) · The University of Hong Kong · NCT06155604Use of Dapagliflozin in Primary Prevention of Cardiotoxicity of Anthracycline Chemotherapy in Breast Cancer Patients
Phase 2 · 1 location(s) · University Medical Centre Ljubljana · NCT07245069Dapagliflozin for Cardio-renal Protection After ICU Discharge
Phase 3 · 2 location(s) · Assistance Publique - Hôpitaux de Paris · NCT07025629Adult Congenital Heart Disease International EValuation of the Effectiveness of SGLT2i Registry
Phase N/A · 11 location(s) · Leiden University Medical Center · NCT06932081Protecting the Kidney's Proximal Tubules From Platinum-Based Chemotherapy Toxicity
Phase 2 · 1 location(s) · Instituto Nacional de Ciencias Medicas y Nutricion Salvador · NCT07018622Sotagliflozin in Patients With Heart Failure Symptoms and Type 1 Diabetes
Phase 2 · 17 location(s) · University of Dundee · NCT06435156
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.